Clinical Trial: Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]

Official Title: Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Brief Summary: As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.

Detailed Summary: The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint.
Sponsor: University of Cologne

Current Primary Outcome: All-cause mortality [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Inhospital all-cause mortality [ Time Frame: 1 month ]

Original Secondary Outcome: Same as current

Information By: University of Cologne

Dates:
Date Received: March 9, 2015
Date Started: January 2013
Date Completion: December 2020
Last Updated: May 1, 2017
Last Verified: May 2017